Standard
Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes. / Courrèges, J-P; Vilsbøll, Tina; Zdravkovic, M; Le Thi Thanh, Xuan; Krarup, T; Schmitz, Ole; Verhoeven, R; Bugáñová, I; Madsbad, S.
I:
Diabetic Medicine, Bind 25, Nr. 9, 01.09.2008, s. 1129-31.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Courrèges, J-P
, Vilsbøll, T, Zdravkovic, M, Le Thi Thanh, X, Krarup, T, Schmitz, O, Verhoeven, R, Bugáñová, I
& Madsbad, S 2008, '
Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes',
Diabetic Medicine, bind 25, nr. 9, s. 1129-31.
https://doi.org/10.1111/j.1464-5491.2008.02484.xAPA
Courrèges, J-P.
, Vilsbøll, T., Zdravkovic, M., Le Thi Thanh, X., Krarup, T., Schmitz, O., Verhoeven, R., Bugáñová, I.
, & Madsbad, S. (2008).
Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes.
Diabetic Medicine,
25(9), 1129-31.
https://doi.org/10.1111/j.1464-5491.2008.02484.xVancouver
Courrèges J-P
, Vilsbøll T, Zdravkovic M, Le Thi Thanh X, Krarup T, Schmitz O o.a.
Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes.
Diabetic Medicine. 2008 sep. 1;25(9):1129-31.
https://doi.org/10.1111/j.1464-5491.2008.02484.xAuthor
Courrèges, J-P ; Vilsbøll, Tina ; Zdravkovic, M ; Le Thi Thanh, Xuan ; Krarup, T ; Schmitz, Ole ; Verhoeven, R ; Bugáñová, I ; Madsbad, S. / Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes. I: Diabetic Medicine. 2008 ; Bind 25, Nr. 9. s. 1129-31.
Bibtex
@article{5bd91833ba3744c9ae17f464c1850b58,
title = "Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes",
author = "J-P Courr{\`e}ges and Tina Vilsb{\o}ll and M Zdravkovic and {Le Thi Thanh}, Xuan and T Krarup and Ole Schmitz and R Verhoeven and I Bug{\'a}{\~n}ov{\'a} and S Madsbad",
year = "2008",
month = sep,
day = "1",
doi = "http://dx.doi.org/10.1111/j.1464-5491.2008.02484.x",
language = "English",
volume = "25",
pages = "1129--31",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "9",
}
RIS
TY - JOUR
T1 - Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes
AU - Courrèges, J-P
AU - Vilsbøll, Tina
AU - Zdravkovic, M
AU - Le Thi Thanh, Xuan
AU - Krarup, T
AU - Schmitz, Ole
AU - Verhoeven, R
AU - Bugáñová, I
AU - Madsbad, S
PY - 2008/9/1
Y1 - 2008/9/1
U2 - http://dx.doi.org/10.1111/j.1464-5491.2008.02484.x
DO - http://dx.doi.org/10.1111/j.1464-5491.2008.02484.x
M3 - Journal article
VL - 25
SP - 1129
EP - 1131
JO - Diabetic Medicine
JF - Diabetic Medicine
SN - 0742-3071
IS - 9
ER -
